FindTrial
Sign In

To explore the value of serological, salivary and histological examinations in the diagnosis of Sjogren's syndrome

To explore the value of serological, salivary and histological examinations in the diagnosis of Sjogren's syndrome

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100042744
Enrollment
Unknown
Registered
2021-01-27
Start date
2021-02-01
Completion date
Unknown
Last updated
2021-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sjogren syndrome

Interventions

Gold Standard:AECC standards proposed by the United States and European Union in 2020, including primary and secondary.
Index test:1.&#32
Serum&#32
ANA,&#32
anti-SSA&#32
/SSB&#32
antibody
&#32
2.&#32
ultrasonography&#32
of&#32
salivary&#32
glands
3.&#32
nuclide&#32
imaging&#32

Sponsors

Longyan First Affiliated Hospital of Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Dry mouth, dry eyes, bilateral salivary glands repeatedly swelling, suspected Sjogren's syndrome patients.

Exclusion criteria

Exclusion criteria: 1. Medical history or surgical history of parotid and submandibular gland tumors on either side; 2. Acute or chronic inflammation of salivary glands; 3. Head and neck radiotherapy or chemotherapy history; 4. History of sialolithiasis; 5. Sarcoidosis; 6. A history of taking antiacetylcholine drugs 7. Hepatitis C infection; 8. AIDS; 9. Scoagulation abnormalities; 10. Pregnant and lying-in woman.

Design outcomes

Primary

MeasureTime frame
Ultrasound VTQ values of salivary glands;Salivary gland nuclide imaging UR;Salivary gland MSR;—

Countries

China

Contacts

Public ContactLin Min

Longyan First Affiliated Hospital of Fujian Medical University

269129376@qq.com+86 18359186280

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026